By Mark NiquetteDecember 4, 2020, 6:57 PM EST Updated on
- President-elect now officially tops 270 electoral votes
- Hawaii and New Jersey, which he also won, have yet to certify
Joe Biden now officially has more than the 270 Electoral College votes he needs to claim the presidency after California certified its election results on Friday evening.
Secretary of State Alex Padilla approved the results of Biden’s victory, according to his office, which Democratic Governor Gavin Newsom will use to prepare the Certificate of Ascertainment appointing the state’s 55 electors for Biden.
The electors will meet in their states on Dec. 14 to cast their votes, which Congress will tally in a joint session on Jan. 6.
Even as Biden and Vice President-elect Kamala Harris proceed with the transition to a new administration, President Donald Trump continues to make unsubstantiated allegations of massive voter fraud, on Twitter and in a lengthly video released this week. But his already slim chances of reversing the election outcome have narrowed even more as courts in several several states have rejected legal challenges brought by his campaign and supporters.
Courts in Nevada and Minnesota handed him two more losses on Friday, dismissing lawsuits seeking to decertify Biden’s victories in those states.
December 5, 2020
WSJ: Where the Vaccines are Going
The U.K. this week became the first Western country to authorize the use of a Covid-19 vaccine. As major vaccines inch closer to approval, western countries have bought large supplies for their populations.
It will be many months before those quantities are produced, as Pfizer has struggled to secure the raw materials and new technology it needs to produce even half of the 100 million doses it hoped to have ready worldwide by the end of this year. The U.K., which expected to get up to 10 million doses this year, now anticipates receiving about half in that time frame.
The next likely candidate, Moderna Inc., only has 160 million doses lined up for the EU and will make 20 million doses of its vaccine available for the U.S. this month. An additional 85 million to 100 million doses are expected to be available for the U.S. during the first quarter of 2021.
Moderna’s vaccine, as well as Pfizer’s, requires two doses. The vaccine uses similar mRNA technology as Pfizer’s, and the manufacturing process is challenging. It involves injecting tiny strands of viral DNA into a microscopic nanoparticle of fat at a stable temperature, without allowing oxygen to seep into the materials—on an industrial scale.
That leaves Europe and America dependent on less cutting-edge vaccines that are far easier to produce, but whose future is cloudier. The most important of those is a two-dose shot by AstraZeneca and Oxford University. The EU has purchased 400 million doses and the U.S. has bought 500 million.
This Wall Street Journal article shows pictorially where the Pfizer, Moderna, Astrazeneca, Sputnik and the Chinese vaccines will be going to the different countries and continents. Reference